RecruitingPHASE1, PHASE2NCT03539822

Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies

Studying Leukoencephalopathy with calcifications and cysts

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Anwaar Saeed
Principal Investigator
Anwaar Saeed, MD
University of Pittsburgh
Intervention
Cabozantinib(drug)
Enrollment
117 target
Eligibility
18 years · All sexes
Timeline
20182029

Study locations (2)

Collaborators

AstraZeneca · Exelixis

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03539822 on ClinicalTrials.gov

Other trials for Leukoencephalopathy with calcifications and cysts

Additional recruiting or active studies for the same condition.

See all trials for Leukoencephalopathy with calcifications and cysts

← Back to all trials